Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation
- 1 March 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (6) , 542-543
- https://doi.org/10.1038/sj.bmt.1703414
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantationBone Marrow Transplantation, 2000
- Bone Marrow Transplant Associated Thrombotic MicroangiopathyHematology, 2000
- Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantationBone Marrow Transplantation, 1999
- Thrombotic Thrombocytopenic Purpura and Sporadic Hemolytic-Uremic Syndrome Plasmas Induce Apoptosis in Restricted Lineages of Human Microvascular Endothelial CellsBlood, 1997